| Pharmaceutical active ingredients: |
| CarbinoxaminePhenylpropanolamine |
| Available forms, composition and doses of Rinoretard: |
| N / A |
| Rinoretard medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA51 - Phenylpropanolamine, combinationsR06AA08 - Carbinoxamine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pfizer |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Rinopanteina | Vitamin A; Vitamin B5 (Dexpanthenol) | DMG Italia |
| Rinoparin | Chlorpheniramine Maleate; Pseudoephedrine Hydrochloride | Pasteur Laboratorios |
| Rino-Ped | Sodium Chloride | Stiefel Laboratories |
| Rinoplex | Diphenylpyraline Hydrochloride; Nylidrin Hydrochloride; Salicylamide | Wyeth |
| Rinoplex CR | Diphenylpyraline Hydrochloride; Nylidrin Hydrochloride; Propyphenazone | Wyeth |
| Rinorix | Tramazoline Hydrochloride | Boehringer Ingelheim |
| Rinos | Cineole; Thymol; Xylometazoline Hydrochloride | L. Molteni & C. Dei Fratelli Alitti |
| Rinos-A | Naphazoline Hydrochloride | Americano de Farmacoterapia Laboratorio |
| Rinosbon | Chlorpheniramine Maleate; Dexamethasone; Phenylephrine Hydrochloride | Eversil Produtos Farmaceuticos Industria e Comercio |
| Rinosed | Acetaminophen; Phenylpropanolamine; Triprolidine Hydrochloride | Varun Life Sciences |